Free American Society for Microbiology ABMM Exam Questions

Question 1

A research laboratory is investigating the mechanisms of viral latency in herpes simplex virus type 1 (HSV1). During latency in sensory neurons, the viral genome exists as a circular episome. Whichof the following viral gene products is thought to play a crucial role in maintaining this latent state and preventing viral gene expression?

A : Immediate-early (IE) proteins such as ICP4 and ICP27.

B : Early (E) proteins such as thymidine kinase and DNA polymerase.

C : Late (L) proteins such as structural glycoproteins.

D : Latency-associated transcripts (LATs).

Answer: D

Question 2

A clinical microbiology laboratory is using flow cytometry to analyze lymphocyte subsets in a patient with suspected immunodeficiency. Which of the following cell surface markers is typically used to identify helper T cells?

A : CD8

B : CD4

C : CD19

D : CD56

Answer: B

Question 3

A clinical microbiology laboratory is using flow cytometry to analyze lymphocyte subsets in a patient with suspected immunodeficiency. Which of the following cell surface markers is typically used to identify helper T cells?

A : CD8

B : CD4

C : CD19

D : CD56

Answer: B

Question 4

The human virome, the collection of viruses that reside in and on the human body, is increasinglyrecognized for its role in health and disease. Which of the following statements regarding the human virome is MOST accurate?

A : The human virome is primarily composed of pathogenic viruses that cause acute infections.

B : The composition of the human virome is relatively stable over time and is not influenced by environmental factors.

C : Bacteriophages, viruses that infect bacteria, are a significant component of the human gut virome.

D : The human virome is largely independent of the host's immune status.

Answer: C

Question 5

A clinical laboratory manager is implementing a new automated blood culture system. Which aspect is LEAST likely to be part of the initial verification/validation process before clinical use?

A : Comparison of time-to-detection with the previous system

B : Verification of detection of a panel of common bloodstream pathogens

C : Assessment of the system's contamination rate over one year of routine use

D : Establishing workflow and training competency for laboratory staff

Answer: C